Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 6
1988 2
1991 1
1993 2
1994 1
1997 5
1999 1
2000 3
2002 2
2003 4
2004 2
2005 4
2006 1
2007 3
2008 2
2009 5
2010 2
2011 4
2012 3
2013 2
2014 2
2015 2
2016 7
2017 4
2018 4
2019 2
2020 4
2021 7
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Water-soluble fullerene derivatives for drug discovery.
Nakamura S, Mashino T. Nakamura S, et al. Among authors: mashino t. J Nippon Med Sch. 2012;79(4):248-54. doi: 10.1272/jnms.79.248. J Nippon Med Sch. 2012. PMID: 22976602 Free article. Review.
Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease.
Katagishi D, Yasuda D, Takahashi K, Nakamura S, Mashino T, Ohe T. Katagishi D, et al. Among authors: mashino t. Bioorg Med Chem Lett. 2023 Jan 15;80:129121. doi: 10.1016/j.bmcl.2022.129121. Epub 2022 Dec 29. Bioorg Med Chem Lett. 2023. PMID: 36587873 Free PMC article.
Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease.
Yasuno T, Ohe T, Kataoka H, Hashimoto K, Ishikawa Y, Furukawa K, Tateishi Y, Kobayashi T, Takahashi K, Nakamura S, Mashino T. Yasuno T, et al. Among authors: mashino t. Bioorg Med Chem Lett. 2021 Jan 1;31:127675. doi: 10.1016/j.bmcl.2020.127675. Epub 2020 Nov 5. Bioorg Med Chem Lett. 2021. PMID: 33161121
Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation.
Ohe T, Umezawa R, Kitagawara Y, Yasuda D, Takahashi K, Nakamura S, Abe A, Sekine S, Ito K, Okunushi K, Morio H, Furihata T, Anzai N, Mashino T. Ohe T, et al. Among authors: mashino t. Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3708-3711. doi: 10.1016/j.bmcl.2018.10.023. Epub 2018 Oct 15. Bioorg Med Chem Lett. 2018. PMID: 30389287
91 results